New China Life Insurance Company Ltd. (1336.HK) Bundle
Founded in September 1996 and listed simultaneously on the Shanghai and Hong Kong exchanges in 2011, New China Life Insurance Company Ltd. has evolved into a state-backed powerhouse with total assets of ¥1.69 trillion as of March 2025 (up 3.6% year-on-year) and a market capitalization of $23.8 billion on July 15, 2025; controlled primarily by state investors led by Central Huijin alongside major stakes from Baosteel and minority holdings by Swiss Re and Fosun, NCI combines a broad product suite-individual, group, life, health and investment contracts-with asset management subsidiaries and technology-driven underwriting to sustain a robust solvency profile (core solvency adequacy ratio 170.72%, comprehensive 256.01% as of June 30, 2025) while recent strategic moves include a 5.45% stake acquisition in Bank of Hangzhou in April 2025 and an AGM in June 2025 approving 2024 financials and dividends - and with first-half 2025 net profit surging 33.5% to RMB14,799 million, the next sections unpack how its ownership, mission, distribution channels and investment mix turn premiums into returns and position NCI for future growth.
New China Life Insurance Company Ltd. (1336.HK): Intro
Founded in September 1996 and headquartered in Beijing, New China Life Insurance Company Ltd. (1336.HK) is a major state-owned life insurer in China focused on individual and group life, annuities, health insurance and investment-linked products. The company expanded capital-market access in 2011 with simultaneous listings on the Shanghai Stock Exchange and the Hong Kong Stock Exchange.- Founding: September 1996 (state-owned enterprise)
- Listings: SSE & HKSE, 2011
- Headquarters: Beijing
- 1996-2010: Rapid branch and agency network expansion across China's provinces, building a retail distribution footprint and bancassurance partnerships.
- 2011: Dual listing on SSE and HKSE to access domestic and international capital.
- March 2025: Total assets reached 1.69 trillion yuan, up 3.6% year-over-year.
- April 2025: Acquired a 5.45% stake in Bank of Hangzhou Co., Ltd., becoming the bank's fourth-largest shareholder.
- June 2025: 2024 AGM approved audited financial reports and dividend distribution plans.
- July 15, 2025: Market capitalization was approximately $23.8 billion.
- Major shareholder status: State-owned background with significant institutional and retail ownership post-listing.
- Strategic investments: Equity stakes in financial institutions (e.g., Bank of Hangzhou) to strengthen bancassurance and asset management synergies.
- Governance: Board and executive team aligned with SOE supervisory frameworks and public-market disclosure requirements.
- Core mission: Provide long-term protection and wealth management solutions for Chinese households while preserving solvency and sustainable returns.
- Strategic priorities: Expand retail distribution, deepen bancassurance, enhance asset management capabilities, and develop health and pension products.
- Product lines: Traditional life insurance, participating policies, universal life, annuities, health insurance, and investment-linked products.
- Distribution: Agency force, bancassurance partnerships, brokers, and digital channels.
- Asset management: Invests premiums in fixed income, equities, real estate and alternative assets to back long-duration liabilities.
- Risk management: Liability-driven investment, actuarial pricing, reinsurance arrangements, and capital adequacy monitoring under China risk-based rules and Solvency frameworks.
- Premium income: Recurring and single-premium inflows from life and health policies form the primary top-line source.
- Investment income: Yield on the invested asset base (bonds, loans, equities) generates interest, dividends and realized/unrealized gains-critical given long-tail liabilities.
- Fee income: Asset management, policy administration, and bancassurance commission/fee arrangements.
- Underwriting result: Net of claims and expense; strong underwriting discipline improves margin.
- Capital and investment strategy: Strategic equity stakes (e.g., Bank of Hangzhou) and portfolio allocation influence long-term returns and solvency ratios.
| Metric | Value | Reference Date |
|---|---|---|
| Total assets | 1.69 trillion yuan | March 2025 |
| YoY asset growth | +3.6% | Mar 2024-Mar 2025 |
| Strategic equity acquisition | 5.45% stake in Bank of Hangzhou | April 2025 |
| Market capitalization | $23.8 billion | July 15, 2025 |
| AGM / corporate actions | 2024 financial reports & dividend plan approved | June 2025 AGM |
- Exploring New China Life Insurance Company Ltd. Investor Profile: Who's Buying and Why?
- Regulatory filings, annual reports and exchange disclosures provide detailed solvency, embedded value and segmental profitability data for deeper analysis.
New China Life Insurance Company Ltd. (1336.HK): History
New China Life Insurance Company Ltd. (1336.HK) was founded in 1996 and listed on the Hong Kong Stock Exchange in 2003. Over its history it has grown from a domestic life insurer to one of China's major life insurance groups, expanding product lines (traditional life, health, pensions, unit-linked and bancassurance) and strengthening asset management capabilities. Key historical milestones include the early 2000s IPO, post-2008 capitalization and governance shifts aligning with state-backed shareholders, and a steady push since the 2010s into wealth management and reinsurance relationships to diversify risk.- Founded: 1996; HKEX listing: 2003 (Ticker: 1336.HK).
- Business expansion: life insurance, health, pension products, asset management, bancassurance partnerships.
- Strategic reinsurance and capital partnerships with global reinsurers (e.g., Swiss Re) since the 2010s.
| Shareholder | Approx. Stake | Notes |
|---|---|---|
| Central Huijin (and state-related entities) | Majority (combined >40%) | Largest single controlling interest; state investment arm overseeing financial SOEs |
| Baosteel Group | Substantial minority (~5-10%) | State-owned industrial group; reflects SOE integration in financial sector |
| Swiss Re | Minority (~1-5%) | Global reinsurance partner and strategic investor |
| Fosun International | Minority (~1-5%) | Private conglomerate investor, diversifying share register |
| Other institutional & retail holders | Remaining shares (~30-45%) | Includes domestic institutions, asset managers and individual investors |
- Central Huijin's position underscores significant government influence over strategy, capital allocation and board composition.
- State-owned investors (e.g., Baosteel) help align NCI with national financial stability and industrial policy goals.
- International investors like Swiss Re provide reinsurance capacity, technical expertise and diversification of ownership.
| Metric | Approximate Value | Comment |
|---|---|---|
| Gross written premiums (annual) | RMB 150-220 billion | Premiums from life, health and accident products; bancassurance is a major channel |
| Total assets | RMB 1.0-1.6 trillion | Insurance assets dominated by bonds, loans, equities and investment real estate |
| Investment income (annual) | RMB 30-80 billion | Yield-sensitive; fixed-income portfolio central to profitability |
| Net profit (annual) | RMB 6-20 billion | Varies with investment yield, actuarial assumptions and one-off items |
| Solvency margin / regulatory ratios | Generally compliant; buffers maintained above regulatory minima | State backing aids capital stability |
- Underwriting: Collect premiums in exchange for life, health and annuity guarantees; pricing and risk selection drive margin.
- Investment: Invest float (policy reserves) primarily in fixed income and selective equities to earn spread between investment yield and guarantee cost.
- Distribution: Bancassurance, agency force, and digital channels - bancassurance remains a high-volume, low-cost channel.
- Reinsurance & risk management: Use of reinsurance partners (e.g., Swiss Re) to cede peak mortality/morbidity and manage capital volatility.
- Asset management & fee income: Growing fees from asset management and wealth-management products mitigate underwriting cyclicality.
- Interest rate environment - investment yields and spread compression affect profitability.
- Policy mix shift - movement toward protection and unit-linked products changes capital and margin profiles.
- Regulatory changes - solvency rules and distribution oversight in China influence capital needs and growth strategy.
- State ownership decisions - strategic allocations, capital injections or governance shifts can materially affect direction.
New China Life Insurance Company Ltd. (1336.HK): Ownership Structure
New China Life Insurance Company Ltd. (1336.HK) positions itself as a customer-centric life insurer focused on protection, wealth planning and long-term financial stability. The company aligns strategy with national priorities-particularly pension, elderly care and healthcare-while reinforcing asset management capabilities to support its life insurance liabilities and product offerings.- Mission: Become China's leading financial services group with insurance at its core-delivering comprehensive protection and wealth planning products.
- Customer focus: Enhance service quality and operational efficiency to meet diverse needs across life, health and pension products.
- Sector priorities: Promote development of old‑age care and healthcare industries to address demographic shifts and policy objectives.
- Asset management: Strengthen investment capabilities to support product guarantees, liquidity and long-term yield stability.
- Corporate culture: Integrate Party building with business operations to reinforce integrity, compliance and social responsibility.
- Employee development: Invest in training, benefits and social security coverage to maintain talent and operational continuity.
- Premium income: Primary revenue from individual and group life and health insurance premiums; recurring premium streams underpin long-term liabilities.
- Investment income: Large portfolio of fixed income, equities and alternatives generates interest, dividends and realized/unrealized gains that fund guarantees and surplus.
- Fee income and other: Wealth-management fees, bancassurance commissions and ancillary services add to revenues.
- Underwriting & risk management: Pricing, reinsurance and reserving practices control net claims and medico-actuarial risks.
| Metric | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net premium income (RMB bn) | 85.0 | 100.0 | 120.0 |
| Net profit (RMB bn) | 4.5 | 6.0 | 8.0 |
| Total assets (RMB bn) | 800.0 | 900.0 | 1,050.0 |
| Core solvency margin ratio (%) | 180 | 220 | 260 |
| Return on equity (ROE %) | 7.0 | 8.5 | 9.5 |
- Major shareholder: New China Life Insurance (Group) Co., Ltd. (controlling shareholder, strategic long‑term investor).
- Public float: Significant Hong Kong‑listed free float with institutional investors and retail holders trading under ticker 1336.HK.
- Governance emphasis: Board and management integrate compliance, risk controls and Party building to align oversight with state and market expectations.
- Capital strategy: Maintain solvency and liquidity buffers, optimize capital allocation between life operations and asset management.
New China Life Insurance Company Ltd. (1336.HK): Mission and Values
New China Life Insurance Company Ltd. (1336.HK) operates as a full‑service insurer focused on life, health and wealth management solutions for individual and institutional clients. Its stated mission centers on financial protection, long‑term wealth accumulation, and serving demographic needs across China and selected international markets. The company emphasizes prudence in risk management, customer‑centric product design, and sustainable investment practices.- Core mission: provide long‑term life and health protection while facilitating savings and investment for policyholders.
- Core values: customer trust, regulatory compliance, disciplined investment and actuarial rigor.
- Governance focus: maintaining capital adequacy, transparent reporting and adherence to industry standards.
- Distribution channels: individual insurance, group insurance (employer/affinity), bancassurance, agency force and third‑party intermediaries to reach a broad customer base.
- Product segmentation: tailored propositions for retail life, retirement accumulation, health & accident cover, and investment‑linked products for wealth management.
- Sales dynamics: combining traditional agent networks with bancassurance and digital channels to balance scale and efficiency.
| Product Category | Main Features | Target Customers |
|---|---|---|
| Traditional life insurance | Guaranteed benefits, long‑term protection | Mass retail and middle‑income families |
| Health & accident insurance | Medical reimbursement, critical illness cover | Individuals and corporate group plans |
| Investment‑linked & savings products | Unit‑linked or participating policies for wealth accumulation | Affluent clients and retirement planners |
| Group insurance | Employee benefits, bulk underwriting | Corporates, SOEs and institutions |
- Funds managed via subsidiaries, including New China Life Insurance Asset Management Company and New China Life Insurance Asset Management Company (Hong Kong), which handle asset allocation, portfolio construction and investment operations.
- Investment strategy combines fixed income, equities and alternative allocations to match long‑dated liabilities and optimize risk‑adjusted returns.
- Prudential asset‑liability management is used to align duration and cashflow profiles with insurance obligations.
- Digital initiatives: customer portals, tele‑underwriting and e‑policy issuance to reduce friction and improve conversion.
- Data analytics: predictive modelling and risk scoring for underwriting, pricing and lapse management to boost operational efficiency.
- Automation: process automation in claims adjudication and policy servicing to lower expense ratios and improve customer experience.
- Core solvency adequacy ratio: 170.72% (as of June 30, 2025).
- Comprehensive solvency adequacy ratio: 256.01% (as of June 30, 2025).
- Compliance: operates under China's insurance regulatory framework and international best practices for reporting and risk governance.
- Underwriting margin: earned premiums less claims and acquisition/maintenance expenses drive core underwriting profit (or loss).
- Investment returns: yield on insurance assets and realized/unrealized gains from the investment portfolio materially affect overall profitability.
- Fee income: wealth management and asset management fees from third‑party and in‑house products contribute non‑insurance revenue.
- Cost control: optimizing distribution mix and digitizing operations lowers acquisition and maintenance costs, improving margins.
New China Life Insurance Company Ltd. (1336.HK): How It Works
New China Life Insurance Company Ltd. (1336.HK) operates as a major Chinese life insurer combining insurance underwriting, asset management and distribution networks to generate revenue and shareholder value. Its operating model revolves around three integrated pillars: protection and saving products sold to individuals and groups, active investment management of insurance float, and fee-based services through asset management and bancassurance partners.- Primary revenue sources: individual life insurance premiums, group life/employee-benefit premiums, health and accident insurance, and investment-type contracts (savings/endowments, annuities).
- Investment income: returns from a diversified portfolio of fixed income, equity, alternative investments and cash management backed by policyholder reserves.
- Fee income: asset management fees and bancassurance/service fees from subsidiaries and third-party mandates.
- Distribution & scale: agency force, bancassurance, and digital channels that increase reach, lower per-policy acquisition costs, and improve persistency.
- Customer-centric strategy: product mix optimization toward protection and long-duration savings to improve margins and retention.
| Metric | Figure / Description |
|---|---|
| Reported net profit (H1 2025) | RMB 14,799 million (+33.5% vs prior year) |
| Primary product mix | Life protection & savings, health & accident, group schemes, investment-linked contracts |
| Investment portfolio (typical allocation) | Fixed income ~60-75%, Equities ~10-20%, Alternatives & others ~5-15% (company manages duration & credit mix) |
| Fee & other income | Asset management fees from subsidiaries; bancassurance/service fees and minor recurring fees |
| Scale advantages | Large premium base and policyholder reserves that reduce unit costs and support diversified investing |
- How underwriting generates margin: premium income minus claims & acquisition costs; higher protection mix and better persistency improve margin over time.
- How investment operations add value: insurance float (policyholder reserves) is invested to earn spread between investment returns and guaranteed/expected policy yields.
- Risk management: asset-liability matching, credit selection, duration management and diversification to protect surplus and solvency.
- Distribution economics: economies of scale from agency and bancassurance lower acquisition costs per policy and improve lifetime value.
- Premium growth and product mix shift to higher-margin products.
- Higher investment returns on a large asset base, driving investment income and net investment gains.
- Fee income expansion via asset management scale and third-party mandates.
- Cost control and digitization improving expense ratios and persistency.
New China Life Insurance Company Ltd. (1336.HK): How It Makes Money
New China Life Insurance Company Ltd. (1336.HK) generates profits primarily by underwriting life and health insurance risks, collecting premiums, investing those premiums across fixed income and equity markets, and earning fee-based income from asset management and pension administration. The group's customer-centric product diversification (term, whole life, annuities, healthcare riders) and distribution mix (agency force, bancassurance, digital channels, and brokers) underpin recurring premium flows and cross-sell opportunities.- Primary revenue streams: net written premiums, investment income (interest, dividends, realised/unrealised gains), and fee & commission income from asset management and pension services.
- Cost drivers: claims & benefits paid, acquisition costs (agent commissions), claims reserves provisioning, and operating/technology investments.
- Growth levers: product diversification (healthcare, annuities, long-term care), digital distribution, bancassurance expansion, and strategic partnerships.
| Metric | Data / Notes |
|---|---|
| Market capitalization (as of 15 Jul 2025) | $23.8 billion |
| Net profit change (H1 2025) | +33.5% (year-on-year) |
| Ownership structure | Diverse: significant stakes held by state-owned enterprises, international investors, and private entities |
| Strategic focus | Customer-centric services, product diversification, technological innovation |
| Alignment with national priorities | Emphasis on old-age care and healthcare to match demographic trends and policy direction |
| Investments & capacity building | Ongoing investments in employee development, technology, and strategic partnerships |
- How investment operations enhance returns: surplus premiums are pooled into diversified portfolios to generate domestic and overseas yield, supporting policyholder payouts and insurer profitability while managing asset-liability matching and regulatory capital requirements.
- Distribution & partnerships: bancassurance and institutional channels boost scaled customer reach and lower marginal acquisition costs relative to pure agency sales.
- Technology & servicing: digital onboarding and claims automation reduce operating costs and improve persistency, contributing to long-term margin expansion.

New China Life Insurance Company Ltd. (1336.HK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.